Cannabinoids: therapeutic use in clinical practice
Medical case reports suggest that cannabinoids extracted from Cannabis sativa have
therapeutic effects; however, the therapeutic employment is limited due to the psychotropic …
therapeutic effects; however, the therapeutic employment is limited due to the psychotropic …
Epidermolysis bullosa
A Bardhan, L Bruckner-Tuderman… - Nature Reviews …, 2020 - nature.com
Epidermolysis bullosa (EB) is an inherited, heterogeneous group of rare genetic dermatoses
characterized by mucocutaneous fragility and blister formation, inducible by often minimal …
characterized by mucocutaneous fragility and blister formation, inducible by often minimal …
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C (ut) annabinoid” System
The endocannabinoid system (ECS) has lately been proven to be an important, multifaceted
homeostatic regulator, which influences a wide-variety of physiological processes all over …
homeostatic regulator, which influences a wide-variety of physiological processes all over …
[HTML][HTML] Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
L Casares, V García, M Garrido-Rodríguez, E Millán… - Redox biology, 2020 - Elsevier
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that attracted a great
attention for its therapeutic potential against different pathologies including skin diseases …
attention for its therapeutic potential against different pathologies including skin diseases …
ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
S Shah, ES Schwenk, RV Sondekoppam… - Regional Anesthesia & …, 2023 - rapm.bmj.com
Background The past two decades have seen an increase in cannabis use due to both
regulatory changes and an interest in potential therapeutic effects of the substance, yet …
regulatory changes and an interest in potential therapeutic effects of the substance, yet …
Phytocannabinoids in the pharmacotherapy of psoriasis
A Wroński, I Jarocka-Karpowicz, A Stasiewicz… - Molecules, 2023 - mdpi.com
Phytocannabinoids are naturally occurring compounds, the main source of which is
Cannabis sativa L. Through direct action or interaction with G protein-coupled receptors …
Cannabis sativa L. Through direct action or interaction with G protein-coupled receptors …
Innovations in the treatment of dystrophic epidermolysis bullosa (DEB): current landscape and prospects
PC Hou, N Del Agua, SM Lwin, CK Hsu… - … and Clinical Risk …, 2023 - Taylor & Francis
Dystrophic epidermolysis bullosa (DEB) is one of the major types of EB, a rare hereditary
group of trauma-induced blistering skin disorders. DEB is caused by inherited pathogenic …
group of trauma-induced blistering skin disorders. DEB is caused by inherited pathogenic …
Prevalence, pathophysiology and management of itch in epidermolysis bullosa
M Papanikolaou, A Onoufriadis… - British Journal of …, 2021 - academic.oup.com
Epidermolysis bullosa (EB) is a highly diverse group of inherited skin disorders, resulting
from mutations in genes encoding proteins of the dermoepidermal junction. Itch (pruritus) is …
from mutations in genes encoding proteins of the dermoepidermal junction. Itch (pruritus) is …
Investigational treatments for epidermolysis bullosa
PC Hou, HT Wang, S Abhee, WT Tu… - American Journal of …, 2021 - Springer
Epidermolysis bullosa (EB) is a heterogeneous group of rare inherited blistering skin
disorders characterized by skin fragility following minor trauma, usually present since birth …
disorders characterized by skin fragility following minor trauma, usually present since birth …
Cannabis and the skin
K Shao, C Stewart, JM Grant-Kels - Clinics in dermatology, 2021 - Elsevier
AbstractUniversity of Conneticut School of Medicine The public and health care providers
are increasingly curious about the potential medical benefits of Cannabis. In vitro and in vivo …
are increasingly curious about the potential medical benefits of Cannabis. In vitro and in vivo …